Health and Human Services Secretary Tom Price said he would review the agency’s recent decision to revoke a public health advisory that had identified a vaccine for a serious communicable disease.
“We will take a close look at the matter, and I will share that with you,” Price said in a statement.
“This is not an easy decision.
I urge you to listen to your employees and listen to the families who deserve to know what the facts are.”
The FDA has said the vaccine for COVID-19 was “not approved by the Food and Drug Administration and not subject to the Federal Food, Drug, and Cosmetic Act.”
The advisory was created in June by the Centers for Disease Control and Prevention and the U.S. Department of Health and the Environmental Protection Agency to advise the public on the safety of a vaccine.
The advisory included an unsubstantiated link to a potentially fatal strain of coronavirus.
But some critics have pointed to a lack of rigorous studies showing a causal relationship between the vaccine and the spread of the coronaviral infection.
The FDA said that it was aware of the advisory’s existence and was working to correct it.
The agency also said it would consider revoking the advisory and would look into whether to remove it from public use.
The move came as Price’s administration announced a $2.9 billion budget proposal that includes $8.5 billion in cuts to the NIH, which has been under pressure to rein in spending, including funding for the coronavetavirus vaccine.